Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety

Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety

Massimo Offidani,1 Laura Corvatta,2 Sonia Morè,1 Attilio Olivieri1 1Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy; 2U.O.C. Medicina, Ospedale Profili, Fabriano, ItalyCorrespondence: Massimo OffidaniClinica di Ematologia Azienda Ospedali...

Full description

Bibliographic Details
Main Authors: Offidani M, Corvatta L, Morè S, Olivieri A
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Drug Design, Development and Therapy
Subjects:
multiple myeloma
relapsed
refractory
belantamab mafodotun
antibody-drug conjugate
Online Access:https://www.dovepress.com/belantamab-mafodotin-for-the-treatment-of-multiple-myeloma-an-overview-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/belantamab-mafodotin-for-the-treatment-of-multiple-myeloma-an-overview-peer-reviewed-fulltext-article-DDDT

Similar Items